Literature DB >> 5525841

Multiple sclerosis in Northern Ireland. A study of the date and place of birth of patients.

G A Ashitey, J H Millar.   

Abstract

Entities:  

Mesh：

Year:  1970        PMID： 5525841      PMCID： PMC2385207     

Source DB:  PubMed          Journal:  Ulster Med J        ISSN： 0041-6193


× No keyword cloud information.
  7 in total

1.  Multiple sclerosis in Israel. Prevalence among immigrants and native inhabitants.

Authors:  M ALTER; L HALPERN; L T KURLAND; B BORNSTEIN; U LEIBOWITZ; J SILBERSTEIN
Journal:  Arch Neurol       Date:  1962-10

2.  Geology and multiple sclerosis.

Authors:  H V WARREN
Journal:  Nature       Date:  1959-08-15       Impact factor: 49.962

3.  The distribution of multiple sclerosis in U. S. veterans by birthplace.

Authors:  E D ACHESON; C A BACHRACH
Journal:  Am J Hyg       Date:  1960-07

4.  Studies on multiple sclerosis in Winnepeg, Manitoba, and New Orleans, Louisiana. I. Prevalence; comparison between the patient groups in Winnipeg and New Orleans.

Authors:  K B WESTLUND; L T KURLAND
Journal:  Am J Hyg       Date:  1953-05

5.  Multiple sclerosis and infection from an epidemiologic aspect.

Authors:  J F Kurtzke
Journal:  Neurology       Date:  1968-01       Impact factor: 9.910

6.  Annual incidence, prevalence, and mortality of multiple sclerosis in white South-African-born and in white immigrants to South Africa.

Authors:  G Dean
Journal:  Br Med J       Date:  1967-06-17

7.  The importance of population fertility and consanguinity data being available in medico-social studies; some data on consanguineous marriages in Northern Ireland.

Authors:  S J KILPATRICK; J D MATHERS; A C STEVENSON
Journal:  Ulster Med J       Date:  1955-11-01
  7 in total
  2 in total

1.  A population of MS patients in the west of Ireland.

Authors:  M A O'Reilly
Journal:  Ir J Med Sci       Date:  1990-07       Impact factor: 1.568

Review 2.  The inheritance of MS susceptibility.

Authors:  D Lord; A G O'Farrell; H Staunton; E Keelan
Journal:  Ir J Med Sci       Date:  1990-01       Impact factor: 1.568
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.